Sign in
Taking peopleNo phase

Night breathing support for kids with Down syndrome and sleep apnea

Follows sleep apnea breathing support in children with Down syndrome.

Key facts

Who runs it
Children's Health Ireland
Where
Belfast, Birmingham, Edinburgh, and Southampton, United KingdomSee the 4 sitesAlso in 1 other country, 2 sites
Trial code
Registry title
Clinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea in Children With Down Syndrome
Status
Recruiting
People taking part
200 people, planned
Started
28 Nov 2022
Expected to end
28 Dec 2027
Type of study
Observational, 2 groups
Treatments tested
  • Non-invasive ventilation
Record updated
12 February 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children with Down Syndrome and obstructive sleep apnoea who are about to start breathing support with a mask machine (non-invasive ventilation).

Age
6 Months to 16 Years. Age ≥ 4 months at the start of therapy.
Sex
All sexes can join.
Disease stage
Obstructive sleep apnoea: Obstructive Apnoea Hypopnoea Index > 2 episodes/hour, or sleep breathing symptoms with an Apnoea Hypopnoea Index > 1 episode/hr. Doctors have decided to start non-invasive ventilation.
Earlier treatment
People who already have a breathing support device prescribed cannot join.
Biomarker or test result
Confirmed diagnosis of Down Syndrome.

Main reasons for not taking part

  • Already prescribed a breathing support device
  • Has an artificial airway, such as a breathing tube
  • Taking part in a trial of test support therapies
  • Not willing to follow study steps or tests
  • Not able to use the English language well

This trial only enrols participants with Down syndrome. The registry sentence this rests on: * Individuals with a confirmed diagnosis of Down Syndrome where a clinical decision has been made to initiate respiratory support with non-invasive ventilation.

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Individuals with a confirmed diagnosis of Down Syndrome where a clinical decision has been made to initiate respiratory support with non-invasive ventilation
  • Obstructive Apnoea Hypopnoea Index > 2 episodes/hour or where sleep disordered breathing symptoms occur in combination with an Apnoea Hypopnoea Index > 1 episode/hr. - English language proficiency
  • Age ≥ 4 months at the commencement of therapy

Who cannot take part

  • Individuals on clinical trials of investigational support therapies
  • Individuals not willing to comply with study procedures or assessments
  • Individuals for whom ventilatory support devices are already prescribed and those with artificial airways

Where in United Kingdom

Also in 1 other country, 2 sites

  • Royal Belfast Hospital for Sick ChildrenBelfast, United KingdomContact: Dara O'DonoghueNot yet recruiting
  • Birmingham Children's HospitalBirmingham, United KingdomContact: Priti KeniaNot yet recruiting
  • Royal Hospital for Children & Young PeopleEdinburgh, United KingdomContact: Florian GahleitnerNot yet recruiting
  • Southampton Children's HospitalSouthampton, United KingdomContact: Hazel EvansNot yet recruiting

About the trial

What the trial wants to find out

The goal of this observational study is to learn about the use of non-invasive ventilation for treatment of obstructive sleep apnoea syndrome in children with Down Syndrome. The main questions it aims to answer are:

Read full original descriptionShow less

* What is the impact of non-invasive ventilation on sleep behaviours and quality of life? * What barriers are faced by children and their families in establishing tolerance to non-invasive ventilation?

Participants will be asked to complete questionnaires before and after starting treatment. Researchers will compare this data with the results of sleep studies and non-invasive ventilator downloads recorded as part of standard medical care. A sub-group of up to 20 participants will be invited to take part in 45-60 minute interviews exploring expectations, experiences and barriers encountered during non-invasive ventilation therapy.

The 2 groups in the trial

  • Standard

    In addition to data from clinical assessment, sleep studies and non-invasive ventilator downloads recorded as part of standard care participants will undergo questionnaire assessment of behaviour, quality of life and barriers to tolerating treatment. Participants aged 3 years and above will receive the Child Sleep Habits Questionnaire, Obstructive Sleep Apnoea-18 questionnaire and Adherence Barriers to CPAP (Continuous Positive Airway Pressure) Questionnaire. Participants aged 6 months to 3 years will receive the Brief Infant Sleep Questionnaire, Infant Toddler Quality of Life - Short Form 47, Obstructive Sleep Apnoea -18 Caregiver Concern Domain and a modified version of the Adherence Barriers to CPAP Questionnaire.

    Treatment: Non-invasive ventilation

  • Advanced

    In addition to all elements of the standard testing group, a sub-group of up to 20 participants will be invited to take part in 45-60 minute semi-structured interviews exploring expectations, experiences and barriers encountered.

    Treatment: Non-invasive ventilation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Real World Clinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea Syndrome in Children With Down Syndrome
Plain-language title
Night breathing support for kids with Down syndrome and sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 February 2024